HOME >> MEDICINE >> NEWS
Eyetech Pharmaceuticals, Inc. announces macugen data on treating macular degeneration

NEW ORLEANS, October 21, 2004 -- Eyetech Pharmaceuticals, Inc. (Nasdaq: EYET) today announced that the treatment effect with the investigational drug Macugen (pegaptanib sodium injection) extends for two years in patients with neovascular or wet, age-related macular degeneration (AMD), who are at risk of losing their vision. A treatment benefit was also seen for patients who received Macugen for two years compared to those only receiving one year of therapy.

The data confirm that patients benefit from two years of treatment with Macugen for wet AMD. The second year data for Macugen will be presented by Anthony P. Adamis, M.D., Chief Scientific Officer, Eyetech Pharmaceuticals and Steven Schwartz, M.D., Chief, Retina Division, Jules Stein Eye Institute, University of California, Los Angeles, at the Retina Subspecialty symposium of the American Academy of Ophthalmology Meeting on Friday, October 22, 2004 at 8:00 a.m. Central Time and 10:38 a.m. Central Time respectively.

Eyetech and Pfizer are partnering to develop and market Macugen, a treatment for neovascular or wet AMD, the leading cause of severe vision loss in patients older than 50 years of age in the developed world. Eyetech and Pfizer have filed an NDA for Macugen for neovascular AMD with the FDA. Macugen has been assigned priority review status and the PDUFA date is December 17, 2004.

"We are excited about the new data because they confirm that treatment with Macugen is effective in patients with neovascular AMD who are at risk of losing their vision," said David R. Guyer, M.D., Chief Executive Officer, Eyetech Pharmaceuticals. "The two year data on Macugen demonstrate that longer term use may be beneficial for patients suffering from this chronic disease."

These data are from two, pivotal Phase II/III randomized, multi-center, double-masked studies in patients with all subtypes of neovascular AMD. 1,186 patients were initially randomized to receive one
'"/>


21-Oct-2004


Page: 1 2 3

Related medicine news :

1. The Gerontological Society of America announces Hartford Fellowship recipients
2. TB Alliance announces new drug discovery program with GlaxoSmithKline
3. ASGE announces grant recipients in annual research awards program
4. Novartis announces collaboration with Bayer for EMSELEX
5. American College of Chest Physicians announces new Critical Care Institute
6. Department of Energy announces new agreement with USC, national labs and private company
7. ACP announces international medical fellowship
8. St. Jude Medical announces CRT patients showed improvement in the RHYTHM ICD study
9. St. Jude Medical announces PAVE and DINAMIT clinical trial results
10. National Inventors Hall of Fame announces 2004 class of inventors
11. Joslin announces first international affiliate in Bahrain

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/3/2020)... ... , ... International Dark-Sky Association (IDA) recently bestowed the prestigious ... advanced LED wireless dimming controller, along with the previously IDA approved Dimulator, are ... light pollution. Leo Smith, the Northeast Regional Director for IDA says “We are ...
(Date:9/1/2020)... ... September 01, 2020 , ... Feeding Matters , the first organization ... Feeding Disorder (PFD), is pleased to announce that the U.S. Centers for Disease Control ... code) in the next edition of the U.S. International Classification of Diseases (ICD ...
(Date:8/31/2020)... ... August 31, 2020 , ... The Lymphoma ... funding innovative lymphoma research and serving the lymphoma community through a comprehensive series ... Anniversary of Blood Cancer Awareness Month (BCAM) and its international Light it ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... for chiropractors, announced today the launch of its integrated, HIPAA compliant, telehealth solution, ... their virtual practice in under 90 seconds. , According to the U.S. ...
(Date:8/31/2020)... ... ... A Cure for Covid-19 “PTS” with Mediation & Hypnosis , At this very turbulent ... panic, experiencing deep anxiety, immense stress, and right now are needing serious relief from a ... on the planet are experiencing a great degree of emotional discomfort, be it fear or ...
Breaking Medicine News(10 mins):
(Date:8/31/2020)... ... August 31, 2020 , ... Cloudticity announced ... named Cloudticity a Gold winner in the 15th Annual 2020 Network PG’s IT ... o ns from Network Products Guide honoring achievements of world’s best in ...
(Date:8/28/2020)... (PRWEB) , ... August 28, 2020 , ... Dr. ... reproductive and endoscopic surgeon and serves as a clinical professor in the Department of ... of the American Laparoscopy Society & Pacific Coast Reproductive Society and is a Clinical ...
(Date:8/27/2020)... Pa. (PRWEB) , ... August 27, 2020 , ... ... care coordination software, today announced the successful completion of their 2020 System and ... well as their HITRUST® interim assessment and MARS-E compliance assessment. These achievements reflect ...
Breaking Medicine Technology:
Cached News: